|
17 Mar 2020 |
Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
|
|
17 Mar 2020 |
Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
|
|
16 Mar 2020 |
BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
|
|
15 Mar 2020 |
Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development
|
|
13 Mar 2020 |
Medicago Announces Production of a Viable Vaccine Candidate for COVID-19
|
|
12 Mar 2020 |
Virometix Announces Initiation of Phase 1 Clinical Trial With Its V-306 Vaccine Candidate
|
|
11 Mar 2020 |
Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate
|
|
10 Mar 2020 |
Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development
|
|
09 Mar 2020 |
CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection
|
|
08 Mar 2020 |
Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19
|
|
05 Mar 2020 |
Heat Biologics Announces Research Collaboration with University of Miami to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus
|
|
05 Mar 2020 |
EpiVax Accelerates COVID-19 Vaccine Development with UGA's Center for Vaccines and Immunology
|
|
04 Mar 2020 |
Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR Technology™
|
|
04 Mar 2020 |
Heat Biologics Launches Program to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus
|
|
04 Mar 2020 |
Inovio accelerates timeline for COVID-19 DNA vaccine INO-4800
|
|
04 Mar 2020 |
Moderna Completes Enrollment of Cytomegalovirus (CMV) Vaccine (mRNA-1647) Phase 2 Study
|
|
03 Mar 2020 |
Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
|
|
03 Mar 2020 |
PDC*line Pharma announces the administration of a first patient with its therapeutic cancer vaccine candidate (PDC*lung01) targeting non-small cell lung cancer
|
|
02 Mar 2020 |
VBI Vaccines Announces Dosing of First Recurrent GBM Patient in Phase 2a Study of Cancer Vaccine Candidate, VBI-1901, in Combination with GSK’s AS01B Adjuvant System
|
|
29 Feb 2020 |
Generex Provides Coronavirus Update: Generex Receives Contract from Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines
|
|
29 Feb 2020 |
Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine
|
|
29 Feb 2020 |
Biohaven's NURTEC™ ODT (rimegepant) Receives FDA Approval for the Acute Treatment of Migraine in Adults
|
|
29 Feb 2020 |
Anokion Announces Initiation of Patient Dosing in Phase 1 Clinical Trial of KAN-101 in Celiac Disease
|
|
27 Feb 2020 |
Advaxis Announces Updated Positive Clinical Data in Ongoing Phase 1/2 ADXS-503 Trial in NSCLC at I/O 360° Conference
|
|
26 Feb 2020 |
Novavax Advances Development of Novel COVID-19 Vaccine
|
